The Effects of Ilioinguinal Nerve Block on Chronic Pain in Patients in Inguinal Hernia With Spinal Anesthesia
Research on the Effects of Ilioinguinal Nerve Block on Chronic Pain in Patients Who Undergo Inguinal Hernia With Spinal Anesthesia
1 other identifier
interventional
60
1 country
1
Brief Summary
Regional anesthesia is a popular anesthetic method in patients who will undergo an inguinal hernia operation. Researchers known that pain in the operating area is a complaint that impairs the quality of life for patients in the long term after the operation. In addition to regional anesthesia, has planned to investigate the effects of applying another drug near the surgery area on pain that may develop in the long term.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2017
CompletedFirst Submitted
Initial submission to the registry
February 29, 2020
CompletedFirst Posted
Study publicly available on registry
March 4, 2020
CompletedMarch 4, 2020
March 1, 2020
4 months
February 29, 2020
March 3, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
acute pain scores( VAS)
Presence of pain was interrogated in the hospital within the first 24 hours (2nd, 6th, 12th, 24th hours), Visüel Analog Scale (VAS) is between 0-10 points, 0 means no pain and 10 means incredible pain.
24 hours
chronic pain scores(LANSS)
The presence of pain that may occur in the 3rd and 6th months can be learned by contacting patients by phone. The Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) is a neuropathic pain scale. In LANSS follow-ups, 12 points or more were associated with neuropathic pain.
6 months
Secondary Outcomes (3)
taken amount of analgesic drugs
48 hours
postoperative complications
48 hours
hospital stay
48 hours
Study Arms (2)
VAS (Visüel Analog Score)
ACTIVE COMPARATORVAS : 0-10 points 0 means: no pain 10 means: incredible pain
LANSS (Leeds Assessment of Neuropathic Symptoms and Signs)
ACTIVE COMPARATORLANSS 0-24 points \>12 points : has chronic neuropathic pain \<12 points: no chronic neuropathic pain
Interventions
The patients underwent inguinal hernia operation randomly classified into two groups in the operating room as; Group I (n:30); spinal block (SA): All patients were given SA in sitting position and 3ml 0.5% hyperbaric bupivacaine was injected in sterile conditions with 25 G injection in L3-4, L4-5 subarachnoid space. Times when the block reached T10 level were recorded.
Group 2 (n:30); SA in sitting position and 3ml 0.5% hyperbaric bupivacaine was injected in sterile conditions with 25 G injection in L3-4, L4-5 subarachnoid space and as a ilioinguinal block (IHNB) 10 ml 5% bupivacaine was injected to patients with peripheric nerve block injection in the reanimation unit after the surgery.
Eligibility Criteria
You may qualify if:
- ASA I-III
- Age 18-65
- Inguinal hernia operation with spinal anesthesia
- Patients who agreed to participate in the study
You may not qualify if:
- Mental retards and communication disorder
- Infection at the injection site
- Patient with a clotting disorder
- Local anesthetic allergy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Health Sciences Bursa Yüksek İhtisas Training and Research Hospital
Bursa, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tugba Onur, MD
2017-17/24
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle İnvestigator
Study Record Dates
First Submitted
February 29, 2020
First Posted
March 4, 2020
Study Start
April 1, 2017
Primary Completion
July 31, 2017
Study Completion
December 31, 2017
Last Updated
March 4, 2020
Record last verified: 2020-03
Data Sharing
- IPD Sharing
- Will not share